Emerging Infectious Disease ISSN: 1080-6059

Molecular Epidemiology of Adenovirus Type 7 in the United States, 1966–2000¹

Dean D. Erdman*

, Wanhong Xu*, Susan I. Gerber†, Gregory C. Gray‡, David Schnurr§, Adriana E. Kajon¶, and Larry J. Anderson*

Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †Chicago Department of Public Health, Chicago, Illinois, USA; ‡Naval Health Research Center, San Diego, California, USA; §California Department of Health Services, Berkeley, California, USA; ¶Lovelace Respiratory Research Institute, Albuquerque, New Mexico, USA;

Main Article

Figure

Restriction profiles of representative human adenovirus (Ad) genome types Ad7b (1), Ad7d2 (2), and Ad7h (3) after digestion with selected enzymes, BamHI, Sma I, BstEII, BglII, and BcII. DNA markers II (λ HindIII) and III (λ HindIII/EcoRI).

Figure. Restriction profiles of representative human adenovirus (Ad) genome types Ad7b (1), Ad7d2 (2), and Ad7h (3) after digestion with selected enzymes, BamHI, Sma I, BstEII, BglII, and BcII. DNA markers II (λ HindIII) and III (λ HindIII/EcoRI).

Main Article

¹These data were presented in part at the International Conference on Emerging Infectious Diseases, July 16-19, 2000, Atlanta, GA.

Top of Page

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.